Charlene Blake, MD, PhD

HS Associate Clinical Professor
Poorsattar SP, Blake CM, Manuel SP. In Reply to Nakajima and to Davis and Park. Acad Med. 2022 06 01; 97(6):765.
Poorsattar SP, Blake CM, Manuel SP. Addressing Microaggressions In Academic Medicine. Acad Med. 2021 06 01; 96(6):927.
Boulos NM, Burton BN, Blake CM, Gabriel RA. Quotas or mission? The importance of diversity in anesthesiology. J Clin Anesth. 2020 Feb; 59:116-117.
Burton BN, Boulos NM, Wilkins Y Martinez L, Gabriel RA, Blake CM. Ethnic Disparities in Cardiothoracic Anesthesiology Fellowship Training. J Cardiothorac Vasc Anesth. 2019 06; 33(6):1795-1796.
Blake CM, Kharasch ED, Schwab M, Nagele P. A meta-analysis of CYP2D6 metabolizer phenotype and metoprolol pharmacokinetics. Clin Pharmacol Ther. 2013 Sep; 94(3):394-9.
Brandal S, Blake CM, Sullenger BA, Fortenberry YM. Effects of plasminogen activator inhibitor-1-specific RNA aptamers on cell adhesion, motility, and tube formation. Nucleic Acid Ther. 2011 Dec; 21(6):373-81.
Blake CM, Wang H, Laskowitz DT, Sullenger BA. A reversible aptamer improves outcome and safety in murine models of stroke and hemorrhage. Oligonucleotides. 2011 Feb; 21(1):11-9.
Oney S, Lam RT, Bompiani KM, Blake CM, Quick G, Heidel JD, Liu JY, Mack BC, Davis ME, Leong KW, Sullenger BA. Development of universal antidotes to control aptamer activity. Nat Med. 2009 Oct; 15(10):1224-8.
Blake CM, Sullenger BA, Lawrence DA, Fortenberry YM. Antimetastatic potential of PAI-1-specific RNA aptamers. Oligonucleotides. 2009 Jun; 19(2):117-28.